Daily Markets - Airgas Inks Deal With BAE Systems |
- Airgas Inks Deal With BAE Systems
- Autodesk Unveils AutoCAD Mac
- CEMEX Gets Extension Of Contract
- Natco Challenges Celgene’s Revlimid
- D&B Reaffirms, Declares Acquisition
- Pfizer Inks Deal
- TWC Reaches Agreement With Disney
- Red Signal For AstraZeneca Drug
- Bad News For Labor This Labor Day
- Rockwell Incurs $0.2M On Lobbying
- Forex Trading: EURGBP Tests Key Borderline 100 Day MA At 0.8381
| Airgas Inks Deal With BAE Systems Posted: 06 Sep 2010 07:35 AM PDT Airgas Inc. (NYSE:ARG) inked a five-year deal with British defense and aerospace company, BAE Systems to provide bulk and packaged industrial gas, welding hardgoods and related products along with personal protective equipment (PPE) products. The company will supply the material across the manufacturing facilities of BAE Systems in the United States.
|
| Posted: 06 Sep 2010 07:35 AM PDT Autodesk Inc. (NASDAQ:ADSK) announced to launch a Mac version of its flagship product AutoCAD in October 2010. This announcement is particularly significant as it follows a nearly two decades of detachment of Autodesk from Apple Inc.'s (NASDAQ:AAPL) Macintosh. AutoCAD for the Macintosh will be available exclusively in North America and Europe.
|
| CEMEX Gets Extension Of Contract Posted: 06 Sep 2010 07:05 AM PDT The international supplier of building materials CEMEX, S.A.B. de C.V. (CEMEX) received an extension of the initial contract to supply 350,000 cubic meters of ready-mix concrete for the new Hamburg-Moorburg power plant. The company began delivering building materials to Hamburg-Moorburg from April 2008 and has already produced roughly 310,000 cubic meters of ready-mix concrete. CEMEX produced the ready-mix concrete at the construction site using two mobile mixing plants, having a combined … [visit site to read more]
|
| Natco Challenges Celgene’s Revlimid Posted: 06 Sep 2010 07:05 AM PDT Celgene Corporation (NASDAQ:CELG) received the notification regarding a patent challenge for its lead drug Revlimid (lenalidomide). As per the notification, Indian pharma company Natco Pharma Limited filed an Abbreviated New Drug Application (ANDA) with the US Food and Drug Administration (FDA) seeking the permission to manufacture and market generic versions of Revlimid capsules at strengths of 5, 10, 15 and 25 mg in the US. Last month, Celgene had announced that a generic company is looking to … [visit site to read more]
|
| D&B Reaffirms, Declares Acquisition Posted: 06 Sep 2010 06:35 AM PDT The Dun & Bradstreet Corporation (NYSE:DNB) announced the acquisition of a privately held member of the D&B Worldwide Network, Dun & Bradstreet Australia Holdings Limited (D&B Australia) for approximately $205 million in cash. The D&B Australia is a leading provider of credit and information services in Australia and New Zealand. The company offers commercial risk, receivables management and consumer credit services throughout Australia and New Zealand that enable it to … [visit site to read more]
|
| Posted: 06 Sep 2010 06:35 AM PDT Recently, pharmaceutical giant Pfizer Inc. (NYSE:PFE) inked a deal to buy FoldRx Pharmaceuticals Inc. for an undisclosed amount. Through this acquisition, Pfizer aims to expand its pipeline of drugs for orphan and rare diseases. The deal will see Pfizer pay an upfront fee and future milestone payments to FoldRx.
|
| TWC Reaches Agreement With Disney Posted: 06 Sep 2010 06:35 AM PDT Time Warner Cable Inc (NYSE:TWC) entered into a new expanded programming deal with Walt Disney Co (DIS) to provide programs from ABC Family, Disney Channel, Disney XD, ESPN, ESPN2, ESPNEWS, ESPNU, ESPN Classic, ESPN Deportes and SOAPnet, as well as a handful of Disney-owned ABC affiliates, including WTVD in Durham . Time Warner Cable ended its prolonged dispute with Walt Disney that threatened to deter millions of viewers from watching some of their favorite TV shows and channels. Subscribers … [visit site to read more]
|
| Red Signal For AstraZeneca Drug Posted: 06 Sep 2010 06:05 AM PDT AstraZeneca plc (NYSE:AZN) recently announced that its biologics unit, MedImmune, received yet another Complete Response Letter (CRL) from the US Food and Drug Administration (FDA) for motavizumab, which is being studied for the prevention of serious respiratory syncytial virus (RSV) disease in high-risk infants.
|
| Bad News For Labor This Labor Day Posted: 06 Sep 2010 05:47 AM PDT From Linda Chavez: “The labor movement doesn’t have much to celebrate this Labor Day. Congress first established the national holiday in 1894 at unions’ behest. Since then, the American labor movement’s fortunes rose to their zenith in 1956, when more than three-in-10 workers were union members, only to decline each year after. Today, only 12 percent of workers hold union cards (see top chart). And if you discount union members who are public employees, barely 7 percent of private-sector … [visit site to read more]
|
| Rockwell Incurs $0.2M On Lobbying Posted: 06 Sep 2010 05:35 AM PDT Defense contractor Rockwell Collins Inc. (NYSE:COL) spent $217,317 during the second quarter 2010 on lobbying, which shot up by $63,229 from the year-ago level, but moderated by $22,960 from first-quarter 2010 expenses of $240,097.
|
| Forex Trading: EURGBP Tests Key Borderline 100 Day MA At 0.8381 Posted: 06 Sep 2010 05:29 AM PDT |
| You are subscribed to email updates from Daily Markets To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
| Google Inc., 20 West Kinzie, Chicago IL USA 60610 | |
No comments:
Post a Comment